Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Safety of Thrombophobe Ointment During Pregnancy

Understanding Antithrombotic Therapy in Pregnancy

  • Low molecular weight heparin (LMWH) and unfractionated heparin (UFH) are the anticoagulants of choice during pregnancy as they do not cross the placenta and are considered safe for the fetus, according to the American College of Chest Physicians 1, 2
  • For women requiring long-term anticoagulation who become pregnant, LMWH is recommended over vitamin K antagonists throughout all trimesters, as suggested by the American College of Chest Physicians 3

Specific Recommendations for Thromboprophylaxis in Pregnancy

  • For pregnant women with no prior history of VTE and no thrombophilia, clinical vigilance rather than pharmacologic prophylaxis is suggested, as recommended by the American College of Chest Physicians 4
  • For women with specific risk factors such as mechanical heart valves, prior VTE, or certain thrombophilias, specific anticoagulation regimens are recommended, according to the American College of Chest Physicians 5

Postpartum Considerations

  • Anticoagulants that are safe during breastfeeding include warfarin, acenocoumarol, UFH, and LMWH, as stated by the American College of Chest Physicians 3

Important Caveats and Pitfalls

  • Topical antithrombotic agents like thrombophobe ointment are not specifically addressed in pregnancy guidelines, suggesting insufficient evidence for their safety and efficacy during pregnancy, according to the American College of Chest Physicians 1, 6, 4
  • Systemic absorption of topical medications remains a concern during pregnancy, and without specific safety data, such products should be avoided, as noted by the American College of Chest Physicians 2
  • The decision to use any medication during pregnancy should prioritize fetal safety while providing adequate maternal protection, as recommended by the American College of Chest Physicians 7

Conclusion

  • When considering thromboprophylaxis during pregnancy, clinicians should rely on well-studied parenteral options like LMWH or UFH rather than topical agents with limited safety data, according to the American College of Chest Physicians 8, 9

REFERENCES